ClinicalTrials.Veeva

Menu

Bronchial Thermoplasty for Severe Asthma With Dynamic Hyperinflation (HEAT-SA)

T

Toulouse University Hospital

Status

Completed

Conditions

Asthma
Hyperinflation

Treatments

Procedure: Bronchial thermoplasty for treatment of severe asthma

Study type

Interventional

Funder types

Other

Identifiers

NCT02618551
RC31/14/7422

Details and patient eligibility

About

Bronchial thermoplasty is a treatment for severe asthma that consist in decreasing the thickness of bronchial muscle by heat using a catheter inserted into the bronchi under direct vision with the help of an endoscope This treatment has shown efficacy on symptoms, quality of life and the number of exacerbations related to severe asthma.

This clinical study evaluates the efficiency of this treatment on the dynamic hyperinflation phenomenon (worsening of bronchial obstruction during exercise in patients with asthma contributing to worsening shortness of breath).

Full description

Bronchial thermoplasty is a recently validated bronchoscopic technique for the management of severe asthma that treats smooth muscle by radiofrequency to reduce its thickness. This procedure leads to improved asthma control and quality of life, but also to decreased exacerbations frequency and number of emergencies hospitalizations. This treatment requires 3 procedures every 3 to 4 weeks.

The pathophysiological mechanisms underlying its effectiveness need to be better understood for an improved selection of best candidates. In particular, there is a discrepancy between the improvement observed in symptoms (ACQ), quality of life (AQLQ) and the lack of improvement in forced expiratory volume in 1 second (FEV1). Investigator assume that this paradox is due to an efficiency appearing at effort, targeting dynamic hyperinflation phenomenon.

The objective of this study is to evaluate the influence of bronchial thermoplasty on dynamic hyperinflation in severe asthma. The secondary objectives are to assess the effectiveness of bronchial thermoplasty (ACQ, AQLQ) in a selected population of patients with dynamic hyperinflation and to describe bronchial wall structural changes by probe-based confocal LASER endomicroscopy (pCLE).

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe asthma, uncontrolled despite optimal treatment according to GINA (global initiative for asthma) recommendations
  • At least 2 exacerbations treated by systemic steroids in the last year
  • FEV1 between 40 and 80% of predicted values and dynamic hyperinflation (defined as a decrease in inspiratory capacity by more than 500 ml during exercise)

Exclusion criteria

  • Current asthma exacerbation or respiratory infection
  • History of exacerbation after bronchoscopy
  • FEV1 < 40% of predicted values
  • Oxygen saturation < 90%
  • Contra-indications to ALAIR catheter system : pacemaker or other electronic implanted device
  • Allergy to Remifentanyl or Propofol
  • pregnancy; breastfeeding

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

14 participants in 1 patient group

Intervention
Experimental group
Description:
Patients will be treated by three bronchial thermoplasty sessions.
Treatment:
Procedure: Bronchial thermoplasty for treatment of severe asthma

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems